BIOMARKERS IN SOLID TUMORS - BRCA1, BRCA2 - NGS (TISSUE)

₦ 3,118,500.00

Test Name: BRCA1 and BRCA2 Next Generation Sequencing (NGS) in Solid Tumors

Description: Genetic testing of BRCA1/2 genes in tumor tissue using NGS technology.

Clinical Use: Guides targeted therapy and prognosis in breast and ovarian cancers.

Specimen: Tumor tissue biopsy.